Cocrystal Pharma announces up to $13 million registered direct offering

2 hours ago 1

Cocrystal Pharma (NASDAQ:COCP) has entered into definitive agreements for the purchase and sale of 2.76M shares of its common stock at a purchase price of $1.70 per share in a registered direct offering priced at-the-market under Nasdaq rules.
In a